kin:pathic Competitors

We are a research-based and leading Japanese multinational pharmaceutical company engaged in the marketing and sales of highly ethical products. We have built a strong reputation in the local pharma scene over the years through the efficacy of our products backed by clinical studies and research.We are inspired by a global commitment to the development of innovative healthcare products. Our partnership with the medical community is founded on a shared vision to continuously improve patients’ quality of life. Moreover, we take pride that our company offers patient care programs that benefit both patient and family, providing better access to information and disease management. For more information about our company, please visit our website at: www.otsuka.com.ph

We are Compass, a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care. We believe people living with mental health conditions deserve the possibility of a better future. Our initial focus is advancing COMP360, a proprietary, investigational synthetic psilocybin treatment being evaluated for treatment-resistant depression (TRD) and post-traumatic stress disorder (PTSD). Our goal is to advance treatments that move the field of psychiatry towards treatment options that offer rapid onset and sustained durability, with infrequent dosing. We’re driven by our purpose of unlocking pathways to be—opening futures filled with possibility. Together, we’re on an ambitious journey toward enabling people living with mental health conditions to find clarity through self-discovery. Every journey needs a Compass.

MindMed is now Definium Therapeutics, a rebrand that reflects our commitment to forging a new era of psychiatry by applying precision to psychedelic medicine. Follow our new page at the link below!